These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35356486)

  • 1. Blood-brain barrier dysfunction and reduced cerebrospinal fluid levels of soluble amyloid precursor protein-β in patients with subcortical small-vessel disease.
    Kettunen P; Bjerke M; Eckerström C; Jonsson M; Zetterberg H; Blennow K; Svensson J; Wallin A
    Alzheimers Dement (Amst); 2022; 14(1):e12296. PubMed ID: 35356486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Performance of Cerebrospinal Fluid Neurofilament Light Chain and Soluble Amyloid-β Protein Precursor β in the Subcortical Small Vessel Type of Dementia.
    Axelsson Andrén E; Kettunen P; Bjerke M; Rolstad S; Zetterberg H; Blennow K; Wallin A; Svensson J
    J Alzheimers Dis; 2023; 96(4):1515-1528. PubMed ID: 37980667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease - A consensus report.
    Wallin A; Kapaki E; Boban M; Engelborghs S; Hermann DM; Huisa B; Jonsson M; Kramberger MG; Lossi L; Malojcic B; Mehrabian S; Merighi A; Mukaetova-Ladinska EB; Paraskevas GP; Popescu BO; Ravid R; Traykov L; Tsivgoulis G; Weinstein G; Korczyn A; Bjerke M; Rosenberg G
    BMC Neurol; 2017 May; 17(1):102. PubMed ID: 28535786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cerebrovascular disease on amyloid precursor protein metabolites in cerebrospinal fluid.
    Selnes P; Blennow K; Zetterberg H; Grambaite R; Rosengren L; Johnsen L; Stenset V; Fladby T
    Cerebrospinal Fluid Res; 2010 Jul; 7():10. PubMed ID: 20673341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on Vascular Cognitive Impairment Associated with Subcortical Small-Vessel Disease.
    Wallin A; Román GC; Esiri M; Kettunen P; Svensson J; Paraskevas GP; Kapaki E
    J Alzheimers Dis; 2018; 62(3):1417-1441. PubMed ID: 29562536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid in the differential diagnosis of Alzheimer's disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic.
    Paterson RW; Slattery CF; Poole T; Nicholas JM; Magdalinou NK; Toombs J; Chapman MD; Lunn MP; Heslegrave AJ; Foiani MS; Weston PSJ; Keshavan A; Rohrer JD; Rossor MN; Warren JD; Mummery CJ; Blennow K; Fox NC; Zetterberg H; Schott JM
    Alzheimers Res Ther; 2018 Mar; 10(1):32. PubMed ID: 29558979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shared CSF Biomarker Profile in Idiopathic Normal Pressure Hydrocephalus and Subcortical Small Vessel Disease.
    Jeppsson A; Bjerke M; Hellström P; Blennow K; Zetterberg H; Kettunen P; Wikkelsø C; Wallin A; Tullberg M
    Front Neurol; 2022; 13():839307. PubMed ID: 35309577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study.
    Lewczuk P; Kamrowski-Kruck H; Peters O; Heuser I; Jessen F; Popp J; Bürger K; Hampel H; Frölich L; Wolf S; Prinz B; Jahn H; Luckhaus Ch; Perneczky R; Hüll M; Schröder J; Kessler H; Pantel J; Gertz HJ; Klafki HW; Kölsch H; Reulbach U; Esselmann H; Maler JM; Bibl M; Kornhuber J; Wiltfang J
    Mol Psychiatry; 2010 Feb; 15(2):138-45. PubMed ID: 18663368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients.
    Olsson A; Höglund K; Sjögren M; Andreasen N; Minthon L; Lannfelt L; Buerger K; Möller HJ; Hampel H; Davidsson P; Blennow K
    Exp Neurol; 2003 Sep; 183(1):74-80. PubMed ID: 12957490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with the Subcortical Small Vessel Type of Dementia Have Disturbed Cardiometabolic Risk Profile.
    Axelsson E; Wallin A; Svensson J
    J Alzheimers Dis; 2020; 73(4):1373-1383. PubMed ID: 31929169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid-β metabolism in Niemann-Pick C disease models and patients.
    Mattsson N; Olsson M; Gustavsson MK; Kosicek M; Malnar M; Månsson JE; Blomqvist M; Gobom J; Andreasson U; Brinkmalm G; Vite C; Hecimovic S; Hastings C; Blennow K; Zetterberg H; Portelius E
    Metab Brain Dis; 2012 Dec; 27(4):573-85. PubMed ID: 22935999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low serum HDL-cholesterol is associated with increased risk of the subcortical small vessel type of dementia.
    Axelsson Andrén E; Safi D; Wallin A; Svensson J
    Cereb Circ Cogn Behav; 2024; 6():100229. PubMed ID: 38974908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of alpha- and beta-secretase cleaved amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients.
    Sennvik K; Fastbom J; Blomberg M; Wahlund LO; Winblad B; Benedikz E
    Neurosci Lett; 2000 Jan; 278(3):169-72. PubMed ID: 10653020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical diagnosis of vascular cognitive impairment associated with subcortical small vessels disease.
    Liakakis G
    Hell J Nucl Med; 2019; 22 Suppl():187-193. PubMed ID: 30877737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal Fluid Sulfatide Levels Lack Diagnostic Utility in the Subcortical Small Vessel Type of Dementia.
    Svensson J; Blomqvist M; Kettunen P; Eckerström C; Henricsson M; Jonsson M; Bjerke M; Månsson JE; Wallin A
    J Alzheimers Dis; 2021; 82(2):781-790. PubMed ID: 34092632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential of brain age in identifying early cognitive impairment in subcortical small-vessel disease patients.
    Shi Y; Mao H; Gao Q; Xi G; Zeng S; Ma L; Zhang X; Li L; Wang Z; Ji W; He P; You Y; Chen K; Shao J; Mao X; Fang X; Wang F
    Front Aging Neurosci; 2022; 14():973054. PubMed ID: 36118707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevation of plasma soluble amyloid precursor protein beta in Alzheimer's disease.
    Yun SM; Cho SJ; Jo C; Park MH; Han C; Koh YH
    Arch Gerontol Geriatr; 2020; 87():103995. PubMed ID: 31874328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-derived secreted amyloid-precursor protein-β as a marker for diagnosing Alzheimer's disease.
    Marksteiner J; Humpel C
    Curr Neurovasc Res; 2013 Nov; 10(4):297-303. PubMed ID: 23937201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid/serum albumin quotient (Q-Alb) is not increased in Alzheimer's disease compared to neurological disease controls: a retrospective study on 276 patients.
    Giacopuzzi Grigoli E; Solca F; Milone I; Aiello EN; Dubini A; Ratti A; Torresani E; Poletti B; Ticozzi N; Ciusani E; Silani V; Verde F
    Neurol Sci; 2023 Feb; 44(2):709-713. PubMed ID: 36441343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid biomarker and brain biopsy findings in idiopathic normal pressure hydrocephalus.
    Pyykkö OT; Lumela M; Rummukainen J; Nerg O; Seppälä TT; Herukka SK; Koivisto AM; Alafuzoff I; Puli L; Savolainen S; Soininen H; Jääskeläinen JE; Hiltunen M; Zetterberg H; Leinonen V
    PLoS One; 2014; 9(3):e91974. PubMed ID: 24638077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.